Drug Profile
Research programme: cancer therapies - InterMed
Alternative Names: IMD 000344; IMD 014591; IMD 015213; IMD 019064Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator InterMed Discovery
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Germany
- 20 Aug 2007 Preclinical trials in Cancer in Germany (unspecified route)